Etiologic Classification Criteria of ARCO on Femoral Head Osteonecrosis Part 1: Glucocorticoid-Associated Osteonecrosis

Byung Ho Yoon, Lynne C. Jones, Chung Hwan Chen, Edward Y. Cheng, Quanjun Cui, Wolf Drescher, Wakaba Fukushima, Valerie Gangji, Stuart B. Goodman, Yong Chan Ha, Philippe Hernigou, Marc Hungerford, Richard Iorio, Woo Lam Jo, Vikas Khanduja, Harry Kim, Shin Yoon Kim, Tae Young Kim, Hee Young Lee, Mel S. LeeYoung Kyun Lee, Yun Jong Lee, Michael A. Mont, Takashi Sakai, Nobuhiko Sugano, Masaki Takao, Takuaki Yamamoto, Kyung Hoi Koo

Research output: Contribution to journalArticle

13 Scopus citations

Abstract

Background: Glucocorticoid usage, a leading cause of osteonecrosis of the femoral head (ONFH), and its prevalence was reported in 25%-50% of non-traumatic ONFH patients. Nevertheless, there have been no unified criteria to classify glucocorticoid-associated ONFH (GA-ONFH). In 2015, the Association Research Circulation Osseous addressed the issue of developing a classification scheme. Methods: In June 2017, a task force was set up to conduct a Delphi survey concerning ONFH. The task force invited 28 experts in osteonecrosis/bone circulation from 8 countries. Each round of the Delphi survey consists of questionnaires, analysis of replies, and feedback reports to the panel. After 3 rounds of the survey, the panel reached a consensus on the classification criteria. The response rates were 100% (Round 1), 96% (Round 2), and 100% (Round 3), respectively. Results: The consensus on the classification criteria of GA-ONFH included the following: (1) patients should have a history of glucocorticoid use >2 g of prednisolone or its equivalent within a 3-month period; (2) osteonecrosis should be diagnosed within 2 years after glucocorticoid usage, and (3) patients should not have other risk factor(s) besides glucocorticoids. Conclusion: Association Research Circulation Osseous established classification criteria to standardize clinical studies concerning GA-ONFH.

Original languageEnglish (US)
Pages (from-to)163-168.e1
JournalJournal of Arthroplasty
Volume34
Issue number1
DOIs
StatePublished - Jan 2019

Keywords

  • Delphi
  • avascular necrosis
  • corticosteroid
  • femoral head
  • glucocorticoid
  • osteonecrosis

ASJC Scopus subject areas

  • Orthopedics and Sports Medicine

Fingerprint Dive into the research topics of 'Etiologic Classification Criteria of ARCO on Femoral Head Osteonecrosis Part 1: Glucocorticoid-Associated Osteonecrosis'. Together they form a unique fingerprint.

  • Cite this

    Yoon, B. H., Jones, L. C., Chen, C. H., Cheng, E. Y., Cui, Q., Drescher, W., Fukushima, W., Gangji, V., Goodman, S. B., Ha, Y. C., Hernigou, P., Hungerford, M., Iorio, R., Jo, W. L., Khanduja, V., Kim, H., Kim, S. Y., Kim, T. Y., Lee, H. Y., ... Koo, K. H. (2019). Etiologic Classification Criteria of ARCO on Femoral Head Osteonecrosis Part 1: Glucocorticoid-Associated Osteonecrosis. Journal of Arthroplasty, 34(1), 163-168.e1. https://doi.org/10.1016/j.arth.2018.09.005